Olink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The Company was founded in 2016 and is well established across Europe, North America, and Asia. Olink is headquartered in Uppsala, Sweden.
Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) is dedicated to creating a cancer-free world by integrating scientific research with excellence in education and patient-centered care – a strategy that leads to better methods of prevention, detection and treatment. Ohio State has been a National Cancer Institute (NCI)-designated Comprehensive Cancer Center for 50 years and is funded by the NCI to conduct phase I, II and III clinical trials on novel anticancer drugs provided by the NCI. As the cancer program’s adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet® recognition, the highest honor an organization can receive for quality patient care and professional nursing practice. With 21 floors, more than 1.1 million square feet and 378 inpatient beds, The James is the third-largest cancer hospital in the nation – a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care.
Novogene
Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the world. | Novogene is a global leader in Next-Generation Sequencing (NGS), Proteomics, and Metabolomics services, empowering researchers and organizations with cutting-edge multi-omics solutions. Since our founding in March 2011, we have remained at the forefront of innovation, delivering world-class services to advance discoveries in life sciences, healthcare, and beyond. With state-of-the-art laboratories and operations across the United States, the United Kingdom, Germany, China, Thailand, Korea, Singapore, and Japan, Novogene has established a strong global presence to support scientific advancements worldwide. At Novogene, we have built a highly skilled, interdisciplinary team, with the majority holding advanced degrees from top global institutions. Our high-throughput sequencing and high-performance computing platforms are designed to efficiently handle large-scale genomic data, meeting the evolving demands of life sciences and medical research with secure data storage and powerful bioinformatics analysis. Through extensive collaborations with leading academic institutions, hospitals, pharmaceutical companies, and agricultural enterprises, Novogene continues to shape the future of genomic research and precision medicine. As a trusted genomics partner, we are committed to empowering researchers worldwide with the technology, expertise, and solutions needed to advance genomics and improve life. | Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the globe. Novogene has strong scientific expertise and experience with 45 NGS-related patents, as well as over 950 SCI articles with a total impact factor of more than 7970, including publications in first tiers journals such as Cell, Nature and Science. The UC Davis location of Novogene Corporation Inc. was opened in early 2016. We utilize Illumina platform to serve customers in North and South America, and we also offer PacBio and Nanopore services. Novogene Corporation Inc. is proud to have collaborated with scientists from the USA, Canada, Brazil, Colombia, Mexico, and so many more. We are excited to see this global collaboration and partnership growing. | Novogene is a leading provider of genomic services and solutions with cutting-edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the globe. Novogene has strong scientific expertise and experience with 62 NGS-related patents, as well as nearly 20,000 SCI articles with a total impact factor of nearly 120,000, including publications in first-tier journals such as Cell, Nature and Science. As the largest NGS service provider headquartered in Beijing with branches in Hong Kong China, US, UK, Singapore, Netherlands, and Japan, Novogene was founded in 2011 and has been growing rapidly over the past few years. Novogene has genomic sequencing labs in the US (at The University of California at Davis campus), China, Singapore, and the UK (Cambridge).
NovelBeamUSA
NovelBeamUSA is a USA subdivision of NovelBeam Technology, based in San Jose, CA, and is focused on the development and manufacturing of life science instrumentation. Currently, products include fluorometers and PCR products.
Novaflow
Bioinformatics in minutes, not months. Novaflow gives biotechs, researchers, and clinicians the software and services to turn complex data analysis from a months-long bottleneck into a task that takes minutes. We work across the full range of life sciences data, including sequencing, other omics, imaging, microscopy, and more. Whether your team needs a self-serve platform or hands-on expert support, Novaflow adapts to how you work, so scientists can focus on discovery instead of wrestling with pipelines, file formats, and infrastructure. Researchers at leading institutions including Stanford, Mount Sinai, and USC already rely on Novaflow to accelerate their work, shortening timelines from initial data to actionable insight. If your organization is generating more data than your team can analyze, Novaflow is the bioinformatics partner built to close that gap.
Norgen Biotek Corp
Norgen Biotek is a privately owned Canadian biotechnology company founded in 1998. Norgen is an ISO 9001:2015, ISO 13485:2016 certified fully-integrated Canadian biotechnology company focusing on sample collection, preservation and purification for research and diagnostic applications. Norgen’s ISO 9001, ISO 13485 certifications indicate our commitment to design, develop, manufacture and market high quality products, as well as our commitment to continually improve our company, our products and our quality management system. Norgen holds more than thirty-five issued and pending patents. Norgen has developed a unique platform technology based on a proprietary resin/matrix with many applications including the purification, concentration and clean-up of DNA, RNA, microRNA, proteins and exosomes from various specimen types. The efficient purification of these macromolecules is often the first step in diagnostics and in hundreds of molecular biological applications fueling discovery for genomics and proteomics.
Navigate BioPharma Services
We design innovative biomarker solutions and customized validations based on intended use for clinical development from exploratory to regulated. Our approach is technology agnostic, meaning that we have a selection of platforms and techniques to ensure that you get the right answers. Our teams can apply our genomic, flow, digital pathology, or ligand binding analysis methods for across the spectrum of drug development and manufacturing applications. We collaborate with our clients to achieve shared goals. We offer targeted solutions, end-to-end support, and quality oversight to mitigate the risks and challenges of the regulatory process. Quality is embedded in all of our activities and is owned by each individual, to ensure we do what is right, not just when others are watching. This is the cornerstone of our positive interactions with regulators including EMA, HGRAC, FDA, and CDC. Our deep disease knowledge and team of highly-trained specialists can help you determine which platform will provide the best assessment for your intended use. We know that there are complexities and nuances to the diseases you are developing therapies for, and aligning the questions you need answered with the right analytical method(s) for a particular patient population is critical.
Nacalai USA, Inc.
Nacalai USA is located in San Diego and is a subsidiary of Nacalai Tesque, a reagent company based in Kyoto, Japan. We provide a wide range of research products in the Life Science and Analytical Chemistry fields, including various reagents, 3D cell culture vessels, IHC and protein research related products, HPLC columns, and research chemicals. Our mission is to propose and provide products that enable researchers to conduct their research with ease. If you are having trouble with your research or would like to find products new to you, please stop by our booth!
Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad discovers and commercializes genetic tests that determine the risk of developing disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where critical genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.
MP Biomedicals
MP Biomedicals is a global leader in life sciences and diagnostics, providing high-quality research tools and reagents to support cancer research, drug discovery, and molecular biology applications. With a comprehensive portfolio spanning nucleic acid extraction, cell culture, immunoassays, and protein analysis, we empower scientists with reliable solutions for advancing biomedical breakthroughs. Our commitment to innovation and quality ensures researchers have the resources they need to drive discoveries from bench to bedside.